ReviewCancers2026

Axillary De-Escalation After Neoadjuvant Therapy in cN2/N3 HER2-Positive and Triple-Negative Breast Cancer: Navigating Biological Promise and Clinical Uncertainty.

Kefah Mokbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.